Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3489 |
Dasabuvir
ABT-333,达塞布韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dasabuvir (ABT-333) 是丙型肝炎病毒非结构蛋白 5B 的非核苷抑制剂,是一种 RNA 依赖性 RNA 聚合酶,具有抗 HCV 的潜在活性。 | |||
T15282 |
Filibuvir
PF-00868554 |
HCV Protease; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
Filibuvir (PF-00868554) 是 HCV NS5B RNA 依赖性 RNA 聚合酶的选择性非共价抑制剂。 Filibuvir 抑制基因型 1a 和 1b 复制子,EC50 为 59 nM。 | |||
T6229 |
Daclatasvir
Daklinza,达卡他韦,EBP 883,达拉他韦,BMS-790052 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir (EBP 883) 是一种高度选择性的 HCV NS5A 抑制剂,EC50 为 9-50 pM,适用于细胞培养中的多种 HCV 复制子基因型和 JFH-1 基因型 2a 感染性病毒。 | |||
T15573 |
Inarigivir soproxil
SB9200 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Inarigivir soproxil (SB9200) 是一种先天免疫激动剂。 它还显示出针对耐药丙型肝炎病毒 (HCV) 变体的有效抗病毒活性。在基因型 1 HCV 复制子系统细胞中, HCV 1a/1b 的 EC50 为 2.2 和 1.0 μM。 | |||
T7158 |
Ombitasvir
奥比他韦,ABT-267 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ombitasvir (ABT-267) 是丙型肝炎病毒非结构蛋白 5A 的口服生物可利用的强效抑制剂。对 HCV 基因型 1 至 5 的 EC50 为 0.82 至 19.3 pM,对基因型 6a 的 EC50 为 366 pM。 | |||
T3334 |
Velpatasvir
GS-5816,维帕他韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Velpatasvir (GS-5816) 是一种的 HCV NS5A 抑制剂。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 2.16 μM。 | |||
T3226 |
Paritaprevir
ABT-450,Veruprevir,帕利瑞韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Paritaprevir (ABT-450) 是一种口服生物可利用的合成酰基磺酰胺抑制剂,可抑制丙型肝炎病毒 (HCV) 蛋白酶复合物,由非结构蛋白 3 和 4A (NS3/NS4A) 组成,对 HCV 基因型 1 具有潜在活性。 给药后,paritaprevir 可逆地结合 HCV NS3/NS4A 蛋白酶的活性中心和结合位点,并阻止 NS3/NS4A 蛋白酶介导的多蛋白成熟。这会破坏病毒蛋白的加工和病毒复制复合物的形成,从而抑制病毒在 HCV 基因型 1 感染的宿主细胞中的复制。 NS3 是一种丝氨酸蛋白酶,对于 HCV 多蛋白内多个位点的蛋白水解切割至关重要,并且在 HCV 核糖核酸 (RNA) 复制过程中起关键作用。 NS4A 是 NS3 的激活因子。 HCV 是属于黄病毒科的一种小的、有包膜的单链 RNA 病毒,感染与肝细胞癌 (HCC) 的发展有关。 | |||
T8675 |
Vaniprevir
|
Others | Others |
Vaniprevir is a macrocyclic hepatitis C virus NS3/4a protease inhibitor and is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes. vaniprevir has good plasma exposure and excellent liver exposure in multiple species. | |||
T16715 |
Furaprofen
呋喃洛芬,R803 |
Others | Others |
Furaprofen is substantially more potent against genotype 1a and 1b replicons (EC50, ~30 nM) than against the genotype 2a replicon (EC50:1000 nM). Furaprofen is an effective HCV replication inhibitor. | |||
T30584 |
BRD9092
BRD 9092,BRD-9092 |
||
BRD9092 is an enhancer of reactive oxygen species that are nontoxic or cause genotype-selective cell death. | |||
T24476 |
MK-6169
MK6169 |
||
MK-6169 is an effective Pan-Genotype Hepatitis C Virus NS5A inhibitor. It also has Optimized Activity against Common Resistance-Associated Substitutions. | |||
T73834 | NS5A-IN-2 | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
NS5A-IN-2 (Compound 33)为一种高效的NS5A抑制剂,对HCV基因型1b展现出极高效力,并对基因型3a (GT 3a) 亦具备增强活性与良好的代谢稳定性。 | |||
T19627 |
Ciluprevir
BILN 2061ZW,BILN 2061,BILN-2061ZW,BILN-2061,BILN2061ZW,BILN2061 |
||
Ciluprevir is an effective and selective HCV NS3 protease inhibitor with proven antiviral effect in humans. Ciluprevir may be an antiviral agent for individuals infected with non-genotype-1 HCV. In vitro sensitivity studies with Ciluprevir showed a decrea | |||
T73223 | NS5A-IN-3 | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
NS5A-IN-3 (Compound 15) 为高效NS5A抑制剂,对HCV基因型1b显示出高效力,并对基因型3a (GT 3a) 活性提升以及展现出良好的代谢稳定性。NS5A-IN-3相较于daclatasvir,对基因型1b具有更高的耐药门槛。 | |||
T35043 |
Vedroprevir
GS9451,GS 9451,GS-9451 |
||
Vedroprevir, also known as GS9451, is a selective hepatitis C virus (HCV) NS3 protease inhibitor in the development of the treatment of genotype 1 (GT1) HCV infection. | |||
T27461 |
GSK2336805
GSK 2336805,GSK-2336805,JNJ-56914845,GSK-805,GSK805 |
||
GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6. | |||
T15631 | JTK-853 | Others | Others |
JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase. It also displays effective antiviral activity in HCV replicon cells (EC50s: 0.38 and 0.035 µM in genotype 1a H77 and 1b Con1 strains, respectively). | |||
T75241 |
Ledipasvir hydrochloride
GS-5885 hydrochloride |
||
Ledipasvir (GS-5885) hydrochloride 是抗HCV NS5A 的高效抑制剂,对GT1a 和 GT1b 复制子抑制作用显著,其EC50值仅为34 pM 和 4 pM。此外,Ledipasvir hydrochloride 还能抑制 SARS-CoV 3CLpro, IC50 为1.62 μM。 | |||
T21456 |
Grazoprevir hydrate
Grazoprevir,MK5172,MK 5172,MK-5172 |
||
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medic | |||
T30581 |
BRD5459
BRD-5459,BRD 5459 |
||
BRD5459 is a kind of reactive oxygen species enhancer that is non-toxic or leads to genotype selective cell death. Brd5459 can selectively kill cancer cells in various in vitro and in vivo models. | |||
T70846 |
Deleobuvir sodium
|
||
Deleobuvir sodium is the salt form of Deleobuvir, also known as BI207127, a non-nucleoside hepatitis C virus NS5B polymerase inhibitor for the treatment of hepatitis C. Deleobuvir was tested in combination regimens with pegylated interferon and ribavirin, and in interferon-free regimens with other direct-acting antiviral agents including faldaprevir. Deleobuvir showed that a triple combination of deleobuvir, faldaprevir, and ribavirin performed well in HCV genotype 1b patients. Efficacy fell b... | |||
T74625 |
HCV-IN-41
|
||
HCV-IN-41 (compound 4) 是一种高效的丙肝病毒 (HCV)抑制剂,对 HCV1b、2a、3a 和 4a 的 EC50分别为 0.006762 nM、5.183 nM、1.365 nM 和 142.2 nM。HCV-IN-41 能降低 HCVRNA 的复制。 | |||
T63593 |
Dasabuvir sodium
|
||
Dasabuvir (ABT-333) sodium 是非核苷丙型肝炎病毒 (HCV) 聚合酶抑制剂。Dasabuvir sodium 对 HCV NS5B 基因编码的 RNA 依赖性 RNA 聚合酶 (RNA polymerase) 表现出抑制作用。Dasabuvir sodium 能够抑制基因型 1a (菌株 H77) 复制子 (EC50: 7.7 nM) 和 1b (菌株 Con1) 复制子 (EC50: 1.8 nM)。 | |||
T38131 | (E)-10-Hydroxynortriptyline | ||
(E)-10-Hydroxynortriptyline (E-10-OH-NT) is a metabolite of Nortriptyline . Nortriptyline is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and is used to relieve the symptoms of depression[1]. [1]. Shimoda K, et al. The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients. J Clin Psychopharmacol. 2002 Aug;22(4):371-8. [2]. Shimoda K, et al. Dean L. Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. Biotechnology ... |